Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?
Ya-Nan JinHui-Jiao CaoXiao-Hua GongWang-Jian ZhangTia MarksJi-Jin YaoLiang-Ping XiaPublished in: Journal of cancer research and clinical oncology (2021)
We found three cycles of NAC with CCRT was a positive prognostic indicator for improved DFS for the high-risk group among CA-LANPC. However, whether low-risk patients could benefit from three cycles NAC needs further study.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- rectal cancer
- transcription factor
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- newly diagnosed
- lymph node
- radiation therapy
- sentinel lymph node
- peritoneal dialysis
- patient reported outcomes
- patient reported
- genome wide analysis
- childhood cancer